Sage pharmaceutical study

We are excited to announce the opportunity for people to become involved in the Sage pharmaceutical study in Brisbane. Please contact the Neuroscience team below for more information.

“The Sage Pharmaceuticals Study is a 4-month pharmaceutical trial focusing on the impact of a new medication on cognitive function in individuals with early manifest Huntington’s Disease.

  • Eligible participants should be between 25 and 65 years old and in good overall health.
  • Participants will need to take the study drug daily and attend the University of Queensland Centre for Clinical Research (UQCCR) study clinic at the Royal Brisbane and Women’s Hospital (RBWH) campus approximately 8 times during the 4-month period for various assessments.

More information about the study can be found online at:

 If anyone is interested in learning more about this study, please feel free to email the Neuroscience team at